Original Research
Published on 31 May 2023
Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study
in Cancer Immunity and Immunotherapy
- 5,109 views
- 7 citations











